May 25, 2023

FendX's Nanotechnology Is Featured at Two Industry Conferences and Receives Awards

Welcome aboard! Your submission has been received and you are now a member of the community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
Subscribe to Excellence

Oakville, Ontario--(Newsfile Corp. - May 25, 2023) - FendX Technologies Inc. (CSE: FNDX) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings, announced today that its nanotechnology is featured at two prominent scientific conferences and highlight awards granted for the creation and innovation of the Company's nanotechnology.

38th International Conference of Polymer Processing Society: On May 23, 2023, Professor Tohid Didar, Lead Researcher of FendX's nanotechnology development projects at McMaster University, gave a keynote speech entitled "Micro and Nano Engineered Bio-interfaces for Diagnostics and Preventing Spread of Infectious Diseases" where REPELWRAP™ film and spray nanotechnology will be presented. Prof. Didar will be presenting at the 38th International Conference of the Polymer Processing Society being held in St. Gallen, Switzerland.

Canadian Chemistry Conference and Exhibition (CSC 2023): On June 7, 2023, Dr. Sara Imani, a post-doctoral fellow at McMaster who is working on FendX development projects, will speak on "Flexible Hierarchical Omniphobic Surfaces for Anti-fouling and Biosensing Applications" that will feature the Company's REPELWRAP™ film technology. Dr. Imani's talk will be at the 2023 Canadian Chemistry Conference and Exhibition hosted by the Canadian Society for Chemistry being held in Vancouver, Canada.

In addition, FendX is pleased to announce that its recently licensed spray nanotechnology was awarded best poster and best oral presentation at the 4th International Conference on Materials: Advanced and Emerging Materials and the 8th Nano Today Conference, respectively. Noor Abu Jarad, a McMaster graduate student who created the spray nanotechnology, was the recipient of these awards.

Furthermore, Lead Researchers at McMaster, Professors Leyla Soleymani and Tohid Didar, will be awarded the McMaster Faculty of Engineering Entrepreneurship Award for their creation of the nanotechnology that FendX has licensed from McMaster University at the Applause & Accolades, Lighting the Way Gala on June 8th.

"We are so honored to have such talented McMaster researchers working with us to advance our innovative and novel nanotechnology with the focus of creating films and sprays to protect high touch surfaces from contamination," said Dr. Carolyn Myers, President and CEO of FendX.

About FendX Technologies Inc.

FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.


Dr. Carolyn Myers, CEO and Director

Alyssa Barry, Investor Relations

For more information, please visit and the Company's profile on SEDAR at

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to the plans of the Company, products under development, the advancement of the Company's nanotechnology by researchers at McMaster University, and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's final prospectus dated January 31, 2023, under the heading "Risk Factors." Accordingly, the reader is urged to refer to the Company's prospectus and other filings, publicly available through SEDAR, for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Corporate Logo

To view the source version of this press release, please visit


The work included in this article is based on current events, technical charts, company news releases, and the author’s opinions. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. This publication contains forward-looking statements, including but not limited to comments regarding predictions and projections. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. This publication is provided for informational and entertainment purposes only and is not a recommendation to buy or sell any security. Always thoroughly do your own due diligence and talk to a licensed investment adviser prior to making any investment decisions. Junior resource and biotechnology companies can easily lose 100% of their value so read company profiles on for important risk disclosures. It’s your money and your responsibility.

Other News

See All News

Other Articles

See All Articles